0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Soleno Therapeutics Inc - Trending symbols

Latest News of Soleno Therapeutics Inc

DateTitleRead
2025-07-11
14:19
Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launchRead
2025-07-10
15:13
Soleno Therapeutics prices public offering at $85 per shareRead
2025-07-10
15:07
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common StockRead
2025-07-10
14:13
Soleno Therapeutics stock soars as Stifel reiterates Buy on strong Vykat salesRead
2025-07-10
12:01
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common StockRead
2025-07-10
12:00
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025Read
2025-07-08
13:57
Soleno Therapeutics stock price target raised to $115 by Stifel on strong Vykat demandRead
2025-07-03
17:53
Soleno Therapeutics stock hits 52-week high at 86.84 USDRead
2025-06-26
21:24
TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives BuyRead
2025-06-20
22:04
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR ProspectsRead



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Other Income Expense Net 2,077-7001,3772,2193,596-4623,134-6,101-2,967
EBITDA -7,329-3,513-10,8426,259-4,583-2,221-6,8047,296492

Comments

How you think about this?

Leave a comment

Stay informed about Soleno Therapeutics Inc.

Receive notifications about Soleno Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.